Pfizer Inc., New York, New York, was awarded a $2,047,500,000 modification (P00007) to contract W58P05-21-C-0002 for an additional 300 million doses of COVID-19 vaccine for international donation to low and low-middle income countries. Work will be performed in New York, New York, with an estimated completion date of Sept. 30, 2022. Fiscal 2021 Coronavirus Response and Relief Supplemental Appropriations Act funds in the amount of $2,047,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.
Contract Award: Pfizer Inc. (New York, New York) – $2,047,500,000
Defense Daily Staff
SHARE:
